<VariationArchive VariationID="1444501" VariationName="NM_012388.4(BLOC1S6):c.332_333del (p.Tyr111fs)" VariationType="Deletion" Accession="VCV001444501" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-27" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1388465" VariationID="1444501">
      <GeneList>
        <Gene Symbol="BLOC1S6" FullName="biogenesis of lysosomal organelles complex 1 subunit 6" GeneID="26258" HGNC_ID="HGNC:8549" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45587123" stop="45609716" display_start="45587123" display_stop="45609716" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45879416" stop="45901908" display_start="45879416" display_stop="45901908" Strand="+" />
          </Location>
          <OMIM>604310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012388.4(BLOC1S6):c.332_333del (p.Tyr111fs)</Name>
      <CanonicalSPDI>NC_000015.10:45605445:TAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45605446" stop="45605447" display_start="45605446" display_stop="45605447" variantLength="2" positionVCF="45605445" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45897644" stop="45897645" display_start="45897644" display_stop="45897645" variantLength="2" positionVCF="45897643" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Y111fs</ProteinChange>
      <ProteinChange>I87fs</ProteinChange>
      <ProteinChange>Y116fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.45605447_45605448del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.45605447_45605448del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.45897645_45897646del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.45897645_45897646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028194.2" sequenceAccession="NG_028194" sequenceVersion="2" change="g.23229_23230del">
            <Expression>NG_028194.2:g.23229_23230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001311255.1" sequenceAccession="NM_001311255" sequenceVersion="1" change="c.347_348del">
            <Expression>NM_001311255.1:c.347_348del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001298184.1" sequenceAccession="NP_001298184" sequenceVersion="1" change="p.Tyr116fs">
            <Expression>NP_001298184.1:p.Tyr116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001311256.1" sequenceAccession="NM_001311256" sequenceVersion="1" change="c.259_260del">
            <Expression>NM_001311256.1:c.259_260del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001298185.1" sequenceAccession="NP_001298185" sequenceVersion="1" change="p.Ile87fs">
            <Expression>NP_001298185.1:p.Ile87fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012388.4" sequenceAccession="NM_012388" sequenceVersion="4" change="c.332_333del" MANESelect="true">
            <Expression>NM_012388.4:c.332_333del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036520.1" sequenceAccession="NP_036520" sequenceVersion="1" change="p.Tyr111fs">
            <Expression>NP_036520.1:p.Tyr111fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132350.1" sequenceAccession="NR_132350" sequenceVersion="1" change="n.661_662del">
            <Expression>NR_132350.1:n.661_662del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132351.2" sequenceAccession="NR_132351" sequenceVersion="2" change="n.393_394del">
            <Expression>NR_132351.2:n.393_394del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132352.2" sequenceAccession="NR_132352" sequenceVersion="2" change="n.309_310del">
            <Expression>NR_132352.2:n.309_310del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132353.1" sequenceAccession="NR_132353" sequenceVersion="1" change="n.511_512del">
            <Expression>NR_132353.1:n.511_512del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132354.1" sequenceAccession="NR_132354" sequenceVersion="1" change="n.507_508del">
            <Expression>NR_132354.1:n.507_508del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132355.2" sequenceAccession="NR_132355" sequenceVersion="2" change="n.167_168del">
            <Expression>NR_132355.2:n.167_168del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132356.2" sequenceAccession="NR_132356" sequenceVersion="2" change="n.355_356del">
            <Expression>NR_132356.2:n.355_356del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132358.1" sequenceAccession="NR_132358" sequenceVersion="1" change="n.257_258del">
            <Expression>NR_132358.1:n.257_258del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_132359.2" sequenceAccession="NR_132359" sequenceVersion="2" change="n.125_126del">
            <Expression>NR_132359.2:n.125_126del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_883" sequenceAccession="LRG_883">
            <Expression>LRG_883:g.23229_23230del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_883t1" sequenceAccession="LRG_883t1">
            <Expression>LRG_883t1:c.332_333del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140918991" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012388.4(BLOC1S6):c.332_333del (p.Tyr111fs) AND Hermansky-Pudlak syndrome 9" Accession="RCV001982448" Version="3">
        <ClassifiedConditionList TraitSetID="7583">
          <ClassifiedCondition DB="MedGen" ID="C3280026">Hermansky-Pudlak syndrome 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012388.4(BLOC1S6):c.332_333del (p.Tyr111fs) AND Hermansky-Pudlak syndrome" Accession="RCV002300630" Version="1">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012388.4(BLOC1S6):c.332_333del (p.Tyr111fs) AND BLOC1S6-related disorder" Accession="RCV003401943" Version="4">
        <ClassifiedConditionList TraitSetID="89237">
          <ClassifiedCondition>BLOC1S6-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-31" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-17" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">33543539</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="89237" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69546" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">BLOC1S6-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLOC1S6-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="7583" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16486" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 9</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome+9/8543" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013606" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS9</ElementValue>
                <XRef Type="MIM" ID="614171" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18338" />
                <XRef ID="18338" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="280663" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C3280026" DB="MedGen" />
              <XRef ID="MONDO:0013606" DB="MONDO" />
              <XRef Type="MIM" ID="614171" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5068874" SubmissionDate="2022-10-13" DateLastUpdated="2022-11-05" DateCreated="2022-11-05">
        <ClinVarSubmissionID localKey="NM_012388.3:c.332_333delAT|MedGen:C0079504" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002598874" DateUpdated="2022-11-05" DateCreated="2022-11-05" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: BLOC1S6 c.332_333delAT (p.Tyr111SerfsX16) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream or nearby this variant have been reported in association with Hermansky-Pudlak syndrome 9 in HGMD (p.(His96Leufs*22), p.(Ile118Tyrfs*10)), suggesting that this region of the protein is clinically relevant. The variant was absent in 250154 control chromosomes. To our knowledge, no occurrence of c.332_333delAT in individuals affected with Hermansky-Pudlak Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, classifying the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BLOC1S6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012388.3:c.332_333delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0079504" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12153506</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7690388" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="28961597|BLOC1S6-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004105862" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The BLOC1S6 c.332_333delAT variant is predicted to result in a frameshift and premature protein termination (p.Tyr111Serfs*16). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Loss of function variants in BLOC1S6, such as this frameshift variant, are not yet a well-established mechanism of disease. Therefore, although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BLOC1S6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012388.3:c.332_333delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BLOC1S6-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4244127" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="8253392|MedGen:C3280026" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002221199" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33543539</ID>
          </Citation>
          <Comment>This variant disrupts a region of the BLOC1S6 protein in which other variant(s) (p.Ile118Tyrfs*10) have been determined to be pathogenic (PMID: 33543539). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This sequence change creates a premature translational stop signal (p.Tyr111Serfs*16) in the BLOC1S6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 62 amino acid(s) of the BLOC1S6 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BLOC1S6-related conditions. ClinVar contains an entry for this variant (Variation ID: 1444501). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BLOC1S6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.45897644_45897645del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280026" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7690388" TraitType="Disease" MappingType="Name" MappingValue="BLOC1S6-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="BLOC1S6-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5068874" TraitType="Disease" MappingType="XRef" MappingValue="C0079504" MappingRef="MedGen">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4244127" TraitType="Disease" MappingType="XRef" MappingValue="C3280026" MappingRef="MedGen">
        <MedGen CUI="C3280026" Name="Hermansky-Pudlak syndrome 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

